Eleftherios P. Mamounas, Ming Chen, Joseph A. Sparano, Md Ashequr Rahman, Yating Cheng, Victoria Wang, Robert J. Gray, Priya Rastogi, Eghbal Amidi, Charles E. Geyer, Tommy Boucher, Tanner J. Freeman, Mohammadreza Ramzanpour, Mukund Varma, Hassan Ghani, Caleb Cheng, Casey Bales, Jennifer R. Ribeiro, Hanna Bandos, Nicolas Stransky, Mark R. Miglarese, Matthew J. Oberley, David Spetzler, Milan Radovich, George W. Sledge, Norman Wolmark
External validation of MI Clarity M3T for late DR in the TAILORx translational cohort. A, Kaplan–Meier analysis of late DR comparing MI Clarity M3T risk groups in all patients. B, Multivariable Cox analysis assessing the independent prognostic value of the MI Clarity M3T risk label, adjusted for clinical covariates. C, Kaplan–Meier analysis of late DR comparing MI Clarity M3T risk groups in arms B and C (ITT). LDR, late distant recurrence.